UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tuberculosis and diabetes mellitus: convergence of two epidemics

The Lancet infectious diseases, 2009-12, Vol.9 (12), p.737-746

2009

Volltextzugriff (PDF)

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

PLoS medicine, 2019-07, Vol.16 (7), p.e1002842

2019

Volltextzugriff (PDF)

Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6366-6369

2013

Volltextzugriff (PDF)

Drug–drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model

British journal of clinical pharmacology, 2023-03, Vol.89 (3), p.1216-1221

2023

Volltextzugriff (PDF)

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis

PloS one, 2024-09, Vol.19 (9), p.e0306101

2024

Volltextzugriff (PDF)

The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis

The lancet respiratory medicine, 2019-09, Vol.7 (9), p.820-826

2019

Volltextzugriff (PDF)

Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2780-2787

2013

Volltextzugriff (PDF)

Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco

BMC public health, 2011-02, Vol.11 (1), p.140-140, Article 140

2011

Volltextzugriff (PDF)

Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability

Pathogens (Basel), 2021-12, Vol.11 (1), p.38

2021

Volltextzugriff (PDF)

Treatment default amongst patients with tuberculosis in urban Morocco: predicting and explaining default and post-default sputum smear and drug susceptibility results

PloS one, 2014-04, Vol.9 (4), p.e93574-e93574

2014

Volltextzugriff (PDF)

Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series

AIDS research and therapy, 2022-11, Vol.19 (1), p.56-6, Article 56

2022

Volltextzugriff (PDF)

A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis

BMC medical informatics and decision making, 2022-03, Vol.22 (1), p.56-56, Article 56

2022

Volltextzugriff (PDF)

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial

BMJ open, 2022-11, Vol.12 (11), p.e067765

2022

Volltextzugriff (PDF)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis

Frontiers in pharmacology, 2023-04, Vol.14, p.1055329

2023

Volltextzugriff (PDF)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

PLoS medicine, 2017-01, Vol.14 (1), p.e1002202-e1002202

2017

Volltextzugriff (PDF)

A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis

PloS one, 2016-05, Vol.11 (5), p.e0154778

2016

Volltextzugriff (PDF)

Drug Interactions Involving Combination Antiretroviral Therapy and Other Anti-Infective Agents: Repercussions for Resource-Limited Countries

The Journal of infectious diseases, 2008-10, Vol.198 (7), p.948-961

2008

Volltextzugriff (PDF)

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa

Journal of acquired immune deficiency syndromes (1999), 2016-01, Vol.71 (1), p.31-37

2016

Volltextzugriff (PDF)

Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?

Expert review of clinical pharmacology, 2017-10, Vol.10 (10), p.1027-1036

2017

Volltextzugriff (PDF)

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis

PloS one, 2017-12, Vol.12 (12), p.e0189101

2017

Volltextzugriff (PDF)

High-Dose Rifampin: Shall We Be Bolder?

American journal of respiratory and critical care medicine, 2018-09, Vol.198 (5), p.558-560

Dooley, Kelly E

2018

Volltextzugriff (PDF)

Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes

PLOS global public health, 2024, Vol.4 (5), p.e0002714-e0002714

2024

Volltextzugriff (PDF)

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

The New England journal of medicine, 2021-05, Vol.384 (18), p.1705-1718

2021

Volltextzugriff (PDF)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

Frontiers in pharmacology, 2021-06, Vol.12, p.637618

2021

Volltextzugriff (PDF)

Clinical and diagnostic features of central nervous system tuberculosis in Indian children – a descriptive study

Therapeutic advances in infectious disease, 2024-01, Vol.11

2024

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(164)
Humans
(130)
Tuberculosis
(91)
Microbiology
(71)
Infectious Diseases
(64)
Female
(56)
Pharmacology & Pharmacy
(56)
Tuberculosis - Drug Therapy
(51)
Adult
(48)
Antitubercular Agents - Therapeutic Use
(47)
Male
(44)
Immunology
(41)
Hiv
(38)
Hiv Infections - Drug Therapy
(33)
Human Immunodeficiency Virus
(31)
Pharmacokinetics
(29)
Middle Aged
(27)
Pharmacology
(26)
Respiratory System
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Tuberculosis and diabetes mellitus: convergence of two epidemics

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

Drug–drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis

The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis

Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis

Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco

Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability

Treatment default amongst patients with tuberculosis in urban Morocco: predicting and explaining default and post-default sputum smear and drug susceptibility results

Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series

A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis

Drug Interactions Involving Combination Antiretroviral Therapy and Other Anti-Infective Agents: Repercussions for Resource-Limited Countries

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa

Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis

High-Dose Rifampin: Shall We Be Bolder?

Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

Clinical and diagnostic features of central nervous system tuberculosis in Indian children – a descriptive study

Suchergebnisse filtern